In order to identify genes involved in head and neck carcinogenesis, we compared the gene expression pro®le in matched primary normal epithelial cells and primary head and neck cancer cells from the same patients. A cDNA microarray analysis consisting of 12 530 human genes revealed signi®cant changes in the expression of 213 genes, with 91 genes being up-regulated and 122 being down-regulated. This comprehensive list of genes includes those associated with signal transduction (growth factors), cell structure, cell cycle, transcription, apoptosis, and cell ± cell adhesion. Further analysis of nine genes involved in cell ± cell interaction, using Western blot and/or reverse transcription (RT) ± PCR of four paired cell lines supported the reliability of our microarray analysis. More speci®cally, our study provides the ®rst evidence that claudin-7 and connexin 31.1 are down-regulated in head and neck squamous cell carcinomas (HNSCC) compared to normal cells. These ®ndings provide a large body of information regarding gene expression pro®les associated with head and neck carcinogenesis, and also represent a source of potential targets for HNSCC prevention and/or therapeutics.
Introduction
Head and neck (HN) cancer is the sixth most common cancer in both males and females, in North America (Vokes et al., 1993) . More than 90% of HN cancers are squamous cell carcinomas (SCC) (Wong et al., 1996) .
The overall 5-year-survival rate for patients diagnosed with HN cancer is estimated at 50%, and this percentage has not changed signi®cantly over the past two decades (Wong et al., 1996; Reid et al., 2000) . Preventive strategies aimed at inhibition of various stages of early carcinogenesis are becoming a major focus of investigations. To achieve this goal, a comprehensive understanding of genetic changes associated with HN carcinogenesis is essential. Activation of protooncogenes, such as H-Ras, and inactivation of tumor suppressor genes, including p53, are involved in HN carcinogenesis (Jeeries and Foulkes, 2001) . In addition to their role in oncogenesis, expression of transforming oncogenes has been shown to confer cellular radio-and/ or chemo-resistance (Kasid et al., 1989; Miller et al., 1993; Miura et al., 1997) . The development of HNSCC is accompanied by genetic and epigenetic changes including loss of heterozygosity, gene inactivation by methylation, and/or gene ampli®cation, all of which can alter gene function (Bishop and Schiestl, 2001 ). Thus, genome-wide monitoring of gene expression is of importance to understand HNSCC carcinogenesis.
To this end, we have carried out a cDNA array analysis using Aymetrix probe-sets complementary to approximately 12 530 human genes, to monitor the levels of gene expression within aggregates of primary normal epithelial and malignant HN cells established from the same patient. We identi®ed a comprehensive list of genes that are dierentially expressed between normal and cancer cells, many of which have not previously been identi®ed as involved in HN cancer. We believe that our data reveal not only the complex nature of genetic changes during head and neck carcinogenesis, but also useful information for identifying alternative potential therapeutic targets for HNSCC. comprehensive understanding of the carcinogenic process, as these dierences are likely to represent the coordinated alteration of critical pathways involved in the regulation of cell cycle and cell growth, cell ± cell adhesion and cell motility. We reasoned that using matched normal and malignant tissue from the same patient would circumvent the problem of individual dierences in gene expression. As a ®rst step, we isolated eight paired primary cell lines from four patients, and in each case, we obtained four HNSCC with corresponding normal epithelial cells (Table 1) . More than 95% of the primary normal cells displayed an epithelial morphology, in contrast to the primary cancer cells that displayed an epithelial-like morphology (Figure 1 ). The normal and cancer cell lines demonstrated doubling times of approximately 5 and 2 days, respectively, being shorter in early passage than late passages prior to senescence (passage 10 and over 20 for normal and cancer cells, respectively). We used the cDNA array technique to identify genes that are dierentially expressed in three HNSCC cell lines in comparison to matched normal non-cancerous epithelial cell lines from the same patients. The scatter plot of the dierential expression of the 12 530 genes in three samples and the mean of those samples is shown in Figure 2 . Overall, we identi®ed 213 genes out of 12 530, which are regulated dierently between matched normal and cancer cells. The full list of those commonly deregulated genes is available as supplementary information on our web site (http:// www.jgh.ca/research/ldi/supplementary/index.html). Ninety-one genes, with intensity ratios between 2.5 and 200, were up-regulated, while 122 genes were downregulated with ratios between 7200 and 72.5. Thus, 0.7% of the 12 530 genes were over expressed and 1% were under expressed in the cancer cells. It is therefore notable that the expression levels of 98.3% of all genes studied in this experiment did not dier between normal and malignant squamous cells taken from the same patient.
The altered genes included those associated with signal transduction (growth factors), cell structure, cell cycle, transcription, apoptosis, metabolism, and cell ± cell adhesion (Tables 2 and 3 ). In general, most of the genes that are over-expressed in HNSCC encode for growth factors and cell structure, while those genes that are under-expressed are involved in cell ± cell adhesion and motility, apoptosis and metabolism (Tables 2 and 3 ). Among these groups of genes, we subsequently focused on selected genes involved in cell ± cell interaction and cell motility, because of the broad implication of these classes of genes in carcinogenesis and tumor invasion (Li and Herlyn, 2000; Al Moustafa et al., 2002) . We investigated the expression of nine selected genes from the cell ± cell adhesion and motility group by Western and/or RT ± PCR. These genes included claudin-7, connexin 31.1, Wnt-5a, N-cadherin, E-cadherin, a-catenin, b-catenin (b-catenin gene was not in the Gene Chip used in this study), g-catenin and ®bronectin. The total protein and RNA used in this study were obtained from cancer and normal cells harvested 3 weeks apart and representing passage numbers 5 and 6, respectively. As expected from the array analysis, Wnt-5a, N-cadherin and ®bronectin were found to be up-regulated; whereas claudin-7, E-cadherin, a-catenin, b-catenin, g-catenin, and connexin 31.1 were down-regulated in cancer versus normal cells at the protein and/or RNA levels ( Figure 3A ,B; Tables 2 and 3 ). However, the ®bronectin expression was very low in normal and cancer cells of HNC-008 samples. Thus, we were not able to detect a signi®cant dierence between the normal and cancer cells in this patient. Also in HNC-011 samples, E-cadherin and g-catenin expression are down-regulated in cancer cells in comparison to normal cells as shown by Western blotting ( Figure 3A) ; whereas, no clear dierence is seen between normal and cancer cells by RT ± PCR of these transcripts ( Figure 3B ). The dierence between protein and mRNA expression may be explained by diering rates of translation or protein stability in HNC-011 cancer cells versus their normal counterparts.
Using microarray technology, Villaret et al. (2000) identi®ed genes such as keratin 17 and 19, laminin-5, connexin-26, and VEGF as being dierentially expressed in HNSCC tissues with respect to normal tissue. However, their comparison was based on normal tissues obtained from dierent organs than HN such as tonsil, colon, liver, stomach, kidney and brain of dierent patients. In another study, the same authors identi®ed 17 genes preferentially over-expressed in lung SCC by comparing tissues from dierent organs and patients . They found that some of these genes, such as pemphigus vulgaris antigen gp130 and parathyroid hormonerelated peptide, were also over-expressed in HNSCC tissues . Leethanakul et al. (2000) used laser capture microdissection and cDNA arrays to compare the pattern of expression of cancer-related genes between HNSCC and their matching normal tissues from the same patients. They found 59 genes such as cytokeratins (7, 13, 14, 15, 17, 18, 19) , cyclin D1, b-catenin, Our array analysis revealed a large set of genes that are dierentially expressed between normal and cancer cells that included many genes not previously associated with human HNSCC. Consistent with Leethanakul et al. (2000) , we found that the expression of cytokeratins (13, 15, 17, 18) , cyclin D2, b-catenin, transforming growth factor-b, VEGF, FGF and Wnt were altered in cancer cell in comparison with the normal cells. However, our study is the ®rst to obtain the gene expression pro®le from matched normal epithelial HN and HNSCC cells using primary cell cultures, from the same patient. These results are most comparable to results obtained from studies of normal and malignant tissues using laser capture microscopy, but carry the advantage that ®ndings can be con®rmed by Western blotting and/or RT ± PCR in a more homogeneous population of cells.
The cadherins are a family of homophilic cell adhesion proteins that are expressed in a variety of tissues (Grunwald, 1993) . E-cadherin is the predominant cadherin family member that is expressed in epithelial cells. It is generally localized on the lateral surfaces of epithelial cells in regions of cell ± cell contacts that are known as adheren junctions (Takeichi, 1990 ). These junctions form a belt around each cell, creating a continuous zipper of cell adhesion (Shapiro et al., 1995) . On the cytoplasmic side of the membrane, the E-cadherin molecule is linked to the actin ®laments via catenins complex. This complex includes a-catenin and either b-or g-catenin (Ozawa et al., 1989; Ozawa and Kemler, 1992) . Earlier studies demonstrated that E-cadherin catenins complex is down-regulated in human cancer and metastasis including head and neck cancer (Gofuku et al., 1999; Clavel et al., 2001; Yokoyama et al., 2001) . Several studies also reported that cytokeratin expression patterns contribute to the metastatic ability in human carcinoma cells (Chu et al., 1996; Yang et al., 1997; Morifuji et al., 2000) . Among the genes listed in our data (Tables 2 and 3) , N-cadherin, E-cadherin, acatenin, b-catenin, g-catenin, cytokeratin 16 and 18, integrin-a-3, syndecan-1, laminin, tubulin-a, transforming growth factor-b, interleukin 1-b, tumor necrosis factor, and glutathione S-transferase have been reported by several studies to be dierentially expressed between normal HN and HNSCC (Table 4) . Here we report the dierential expression of other HNSCCassociated genes such as ®bulin-2, claudin-7, connexin 31.1, OB-cadherin-2, OB-cadherin-1, interferon b-2, insulin-like growth factor binding protein-5, (IGFBP-5), and human receptor tyrosine kinase DDR. Moreover, we observed for the ®rst time changes in claudin-7 and connexin 31.1 expression in human HNSCC (Table 3 ; Figure 3A ,B). Claudin-7 is a four transmembrane domain-containing protein and is a member of a recently identi®ed family of proteins, the claudins (Heiskala et al., 2001) . The main function of claudins appears to be as critical components of tight junctions (Heiskala et al., 2001) , and thus could have important cell adhesion functions in HN cancer. Connexins are a family of proteins that constitute the intercellular The ratio of this gene is the average of two cell lines membrane channels of gap junctions (Beyer et al., 1990) . Loss or alteration of intercellular communication has been proposed to play an important role in the process of carcinogenesis (Yamasaki et al., 1999) . Connexin 31.1 is a member of the channel-forming proteins; this protein is over-expressed in mouse mature keratinocyte cells and down-regulated in mouse squamous cell carcinomas (Brissette et al., 1994; Budunova et al., 1995) . By microarray, Western blotting and/or RT ± PCR (Table 3 ; Figure 3A ,B) we showed that claudin-7 and connexin 31.1 levels were lower in the matched SCC cell lines in all paired samples analysed. The role of connexin 31.1, claudin-7, and other members of the claudin family in HNSCC warrant further investigation.
In conclusion, the comprehensive identi®cation and pro®ling of gene expression in human normal and HNSCC cells as reported in this study will help to understand the multistep process of HNSCC development. As has been noted for other cancers (Maniotis et al., 1999; Ono et al., 2000; Hedenfalk et al., 2001) , we believe that this systematic approach toward marker identi®cation will be useful in ®nding new targets to prevent and/or treat HNSCC.
Materials and methods

Tissue samples and primary cell culture
Head and neck cancer and their corresponding normal tissue were obtained with informed consent from 12 patients undergoing surgery. In all cases, the biopsy of normal tissue was taken surrounding the tumor location, and was macroscopically normal. Eight tissue specimens (four cancers and corresponding normal tissues) were washed immediately in cold, sterile, phosphate-buered saline (PBS). After removing excess and damaged epithelium and stromal tissue, the healthy specimens were cut into small pieces and incubated 10 min at 378C in 0.05% Trypsin in 0.53 mM EDTA (Gibco/BRL, Montreal, Canada). Surface epithelium was mechanically separated to dissociate the cells into a single cell suspension. The cells were collected after centrifugation and resuspended in the appropriate growth media: mammary epithelial growth medium for normal cells (MEGM, Clonetics, San Diego, CA, USA); RPMI medium with 10% fetal bovine serum (Gibco/BRL) for cancer cells. Cells were seeded on plastic dishes (Falcon, Montreal, Canada) and fed every 48 h. At 80 ± 90% con¯uence, the cells were trypsinized with 0.05% Trypsin in 0.53 mM EDTA and reseeded at a ratio of 1 : 3.
RNA isolation and microarray analysis
Total RNA was extracted with TRIZOL (Gibco/BRL) according to the manufacturer's instructions. Biotinylated probes for microarray analysis were prepared using 20 mg of total RNA as described below. The total RNA was mixed with 100 pM of T7-(T) 24 primer (Genosys, San Diego, CA, USA) and denatured for 10 min at 708C, then chilled on ice. First strand cDNA synthesis was performed using Superscript II reverse transcriptase (Life Technologies, Toronto, Canada) and second strand synthesis was performed using DNA Polymerase I, E coli DNA ligase and RNase H (Gibco/BRL). The biotinylated probe was prepared from the entire cDNA reaction using the ENZO Bioarray High Yield RNA Transcript Labeling Kit (ENZO Diagnostics, Toronto, Canada). Incubating the puri®ed probe in 16 fragmentation buer for 35 min at 958C reduced the average probe length. Hybridization was performed at 458C for 20 h using 15 mg of biotinylated probe. Following hybridization, the non-speci®cally bound probe was removed by 10 low stringency washes and four high stringency washes performed using a GeneChip Fluidics Station 400 (Aymetrix, San Diego, CA, USA). Speci®cally bound probe was detected by incubating the arrays with SAPE (streptavidin phycoerythrin, Molecular Probes) and scanning the chips using a GeneArray Scanner (Hewlett-Packard, San Diego, CA, USA). The scanned images were analysed using the GeneChip Analysis Suite 3.3 (Aymetrix).
Reverse transcription (RT) ± PCR
RT ± PCR ampli®cation was performed using primer sets for N-cadherin, E-cadherin, a-catenin, b-catenin, g-catenin, connexin 31.1, Wnt-5a, and GAPDH genes (Table 5) . GAPDH was used to control the amounts of cDNA generated from each sample. Synthesis of the ®rst-strand cDNA was carried out using a cDNA kit for RT ± PCR (MBI Fermentas, Toronto, Canada). One ®fth of the RT product was ampli®ed for 30 cycles (1 min at 958C, 1 min at 588C, and 1 min at 728C) followed by an extension of 7 min at 728C. RT ± PCR ampli®cation products were analysed on a 1% agarose gel stained with ethidium bromide.
Western blot analysis
This assay was performed as previously described (Al Moustafa et al., 2002 ) but in the experiments described here, anti-®bronectin, N-cadherin, E-cadherin, a-catenin, b-catenin, and g-catenin (Bio/Can Scienti®c, Toronto, Canada), and claudin-7 mAbs were used for the assays. The claudin mAb was a generous gift from Dr M Furuse (Kyoto University, Japan). Table 5 Primer sets used for RT ± PCR ampli®cation
Gene names Primers
N-cadherin 5'-TGCCCCTCAAGTGTTACCTC-3' 5'-GATGATGATGCAGAGCAGGA-3' E-cadherin 5'-CAGTCAAAAGGCCTCTACGG-3' 5'-GTCACCTTCAGCCATCCTGT-3' a-catenin 5'-CCGAGGTAAAGGACCACTCA-3' 5'-TGCCTTCATCTTCCATGACA-3' b-catenin 5'-TGGATACCTCCCAAGTCCTG-3' 5'-AACGCATGATAGCGTGTCTG-3' g-catenin 5'-ACGCTGGTGACACAGAACAG-3' 5'-CTCCTCCATCCTCACACCAT-3' Connexin 31.1 5'-CACAAGGACTTCGACTGCAA-3' 5'-GCTTGGAGATGAAGCAGTCC-3' Wnt-5a
5'-TGCCACTTGTATCAGGACCA-3' 5'-CACTCTCGTAGGAGCCCTTG-3' GADPH 5'-GAAGGCCATGCCAGTGAGCT-3' 5'-CCGGGAAACTGTGGCGTGAT-3'
